Harnessing γδ T cells in anticancer immunotherapy

Area of Science:

• Immunology
• Cancer Biology
• Cellular Therapy

Background:

• Gamma delta (γδ) T lymphocytes play a role in tissue homeostasis and stress responses.
• They possess potent MHC-unrestricted cytotoxicity and cytokine release capabilities.
• γδ T cells broadly recognize cancer cells, making them promising for immunotherapy.

Purpose of the Study:

• To discuss novel aspects of γδ T cell function in anticancer therapies.
• To explore new clinical implementation strategies for γδ T cells in oncology.
• To move beyond established Vγ9Vδ2 T cell subset manipulation.

Main Methods:

• Review of current literature on γδ T cell functions.
• Analysis of novel γδ T cell subsets, properties, and receptors.
• Discussion of clinical applications and expectations in cancer treatment.

Main Results:

• γδ T cells are effective in limiting malignant cell spread and regulating adaptive immunity.
• Their unique properties make them attractive effectors for cancer immunotherapy.
• Novel strategies are being developed to harness different γδ T cell subsets.

Conclusions:

• γδ T cells offer versatile mechanisms for cancer immunotherapy.
• Future research focuses on expanding the therapeutic potential of various γδ T cell subsets.
• New avenues for clinical implementation are emerging for harnessing γδ T cells against cancer.